Ehg Eye Ct, P.c. | |
9 Cots St Ste 1a Shelton CT 06484-3866 | |
(615) 263-5579 | |
Not Available |
Full Name | Ehg Eye Ct, P.c. |
---|---|
Speciality | Internal Medicine |
Location | 9 Cots St Ste 1a, Shelton, Connecticut |
Authorized Official Name and Position | Gregory Byrne (PRESIDENT) |
Authorized Official Contact | 2147122043 |
Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
Mailing Address | Practice Location Address |
---|---|
Ehg Eye Ct, P.c. 1a Burton Hills Blvd Nashville TN 37215-6187 Ph: (615) 263-5579 | Ehg Eye Ct, P.c. 9 Cots St Ste 1a Shelton CT 06484-3866 Ph: (615) 263-5579 |
NPI Number | 1912585639 |
---|---|
Provider Enumeration Date | 04/01/2021 |
Last Update Date | 08/30/2021 |
Identifier | Type | State | Issuer |
---|---|---|---|
1912585639 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207R00000X | Internal Medicine | (* (Not Available)) | Primary |
News Archive
PANalytical, the world's leading supplier of analytical instrumentation and software for X-ray and related techniques, announces their free webinar on The power of powder - Screening of protein-based pharmaceuticals on 18 February 2016, presented by Irene Margiolaki, assistant professor at the Department of Biology of the University of Patras, Greece and Detlef Beckers, Lead Scientist XRD, PANalytical B.V., The Netherlands
MAP Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has informed the Company that a second pivotal efficacy study is not required for the Company's LEVADEX(TM) new drug application (NDA) submission for the acute treatment of migraine. The Company announced in May 2009 that the efficacy portion of its Phase 3 FREEDOM-301 clinical study of LEVADEX met all four primary endpoints. The Company had previously anticipated initiating a second pivotal efficacy study in the first quarter of 2010.
Researchers at the Virginia Commonwealth University Massey Cancer Center have identified the enzyme sphingosine kinase 2 as a possible new therapeutic target to improve the efficacy of chemotherapy for colon and breast cancer.
The National Institute of Diabetes and Digestive and Kidney Diseases recently awarded Jonathan Wall, PhD, professor in the University of Tennessee Health Science Center's Graduate School of Medicine in Knoxville, a $1.79 million grant for his study titled "Developing a Theranostic Immunotherapy for Systemic Amyloidosis."
Atrium Innovations Inc. (TSX: ATB), a leading developer, manufacturer and marketer of science-based and professionally supported products for the Health and Nutrition industry, today announced various initiatives to support the development of its Wobenzym(R) brand in Germany.
› Verified 9 days ago
Value Based Long Term Care Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 5 Research Dr Ste 2, Shelton, CT 06484 Phone: 781-343-1475 | |
Revival Iv And Wellness Clinic Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 12 Progress Dr Ste 1d, Shelton, CT 06484 Phone: 475-314-3011 Fax: 475-314-3011 | |
John Farens Md Pc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 224 Leavenworth Rd, Shelton, CT 06484 Phone: 203-926-1206 Fax: 203-926-0413 | |
H And B Quality Medical Care Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 2 Ivy Brook Rd Ste 120, Shelton, CT 06484 Phone: 860-754-7407 | |
Value Based Long Term Care B Pc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 5 Research Dr Ste 2, Shelton, CT 06484 Phone: 203-567-5243 | |
Advanced Pain And Regenerative Medical Solutions Corp Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 10 Progress Dr, Shelton, CT 06484 Phone: 203-948-8127 | |
St. Vincents Urgent Care Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 15 Armstrong Rd, Shelton, CT 06484 Phone: 203-929-1109 |